On this page
Auditory neuropathy (OTOF)
This condition results from pathogenic changes in the OTOF gene, which encodes otoferlin, a protein essential for transmitting sound information in the inner ear. Individuals typically present with moderate to profound hearing impairment from birth or early childhood, though hearing ability can fluctuate over time.
Available at Jeen Health
Clinical tests that include this
Overview
Auditory neuropathy refers to a pattern of hearing impairment where the inner ear detects sound normally, but the transmission of that information to the brain is disrupted. When caused by variants in OTOF, this condition accounts for a substantial proportion of inherited hearing loss in children, representing approximately 10% of paediatric sensorineural hearing loss cases. The condition follows an autosomal recessive inheritance pattern, meaning both copies of the gene must carry pathogenic variants for the condition to manifest.
Unlike some forms of hearing loss that progress steadily, auditory neuropathy due to OTOF variants can present with variable severity and fluctuating hearing ability. Some affected individuals experience profound deafness from birth, whilst others maintain partial hearing that may worsen or improve unpredictably. This variability can make diagnosis challenging in early childhood, particularly when routine hearing screening tests produce inconsistent results.
Symptoms & clinical features
The primary clinical feature is hearing impairment that typically becomes apparent in infancy or early childhood. Parents may notice their child does not respond consistently to sounds, fails to develop speech at expected milestones, or struggles to understand spoken language even when sounds appear audible. The hallmark of this condition is a disconnect between the ability to detect sounds and the ability to interpret them: standard hearing tests may show that the ear receives sound vibrations, yet the individual cannot process speech effectively.
Many affected individuals experience fluctuating hearing, where their ability to understand speech varies from day to day or even hour to hour. Background noise presents particular difficulty, as the impaired neural transmission makes it nearly impossible to distinguish speech from ambient sound. Tinnitus, a perception of ringing or buzzing in the ears, occurs in some cases. Unlike other forms of hearing loss, traditional hearing aids often provide limited benefit because the underlying problem lies in signal transmission rather than sound amplification.
Video: Genetics 101
Affected organs
The condition specifically affects the inner ear structures, particularly the inner hair cells within the cochlea and their synaptic connections to auditory nerve fibres. Otoferlin is concentrated at the ribbon synapses of these specialised sensory cells, where it plays a crucial role in coordinating the release of neurotransmitter molecules that carry sound signals to the brain.
Whilst the auditory system bears the primary impact, other organ systems remain unaffected in isolated OTOF-related auditory neuropathy. Vision, cognitive development, motor skills and general physical health typically develop normally, distinguishing this condition from syndromic forms of hearing loss that involve multiple body systems.
Risks & severity
Severity ranges from moderate hearing impairment to profound deafness. Many individuals with OTOF variants present with prelingual deafness, meaning hearing loss is present before speech development begins. The degree of impairment varies between affected individuals, with some retaining limited hearing ability whilst others experience complete deafness.
The fluctuating nature of hearing in some affected individuals can complicate educational planning and communication strategies. Whilst the hearing loss itself does not worsen life expectancy or cause pain, the impact on language acquisition, educational attainment and social development can be substantial without appropriate support and intervention. Cochlear implantation represents an important intervention option for individuals with OTOF variants, with many recipients achieving functional hearing and speech development following device placement.
Genetic causes
Auditory neuropathy in these cases results from pathogenic variants in OTOF, located on chromosome 2. This gene provides instructions for producing otoferlin, a calcium-sensing protein essential for the rapid and sustained release of neurotransmitters at the synapses between inner hair cells and auditory nerve fibres. Normal otoferlin function allows these specialised cells to convert the mechanical vibrations of sound into electrical signals transmitted to the brain.
When both copies of OTOF carry pathogenic variants, otoferlin protein is either absent, structurally abnormal or functionally impaired. The precision timing required for neurotransmitter release at auditory synapses becomes disrupted, preventing accurate sound encoding. Inner hair cells may still detect mechanical vibrations from sound waves, yet they cannot reliably pass this information along the neural pathway to the brain. This breakdown in signal transmission produces the characteristic auditory neuropathy pattern observed during clinical testing.
- OTOF otoferlin
Inheritance pattern
This condition follows an autosomal recessive pattern of inheritance. An affected individual inherits one pathogenic OTOF variant from each parent. Parents who carry a single pathogenic variant typically have normal hearing themselves, as one functional gene copy produces sufficient otoferlin for proper auditory function.
When both parents are carriers, each pregnancy carries a 25% chance of producing an affected child, a 50% chance of producing a carrier child with normal hearing, and a 25% chance of producing a child who inherits two typical gene copies. Siblings of an affected individual have a two-in-three chance of being carriers if they themselves have normal hearing. Carrier testing and reproductive genetic counselling are available through NHS clinical genetics services for families affected by this condition.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
Diagnosis typically begins when routine newborn hearing screening or later developmental assessments identify hearing concerns. The characteristic diagnostic finding is preserved otoacoustic emissions or cochlear microphonics alongside absent or severely abnormal auditory brainstem responses, indicating that the cochlea detects sound but the signal transmission to the brain is impaired.
Genetic testing confirms the diagnosis by identifying pathogenic variants in OTOF. This testing is available through the NHS Genomic Medicine Service under the hearing loss PanelApp, which includes OTOF in its gene set (R67 - Hearing loss). Referral typically occurs through audiology services or paediatricians to clinical genetics or genomic medicine centres. Genetic confirmation is particularly valuable for guiding management decisions and providing families with information about recurrence risks. Genetic counselling helps families understand inheritance patterns, testing options for relatives, and reproductive implications.
Management & lifestyle
Management centres on optimising communication abilities and supporting speech and language development. Cochlear implants represent the primary intervention for individuals with OTOF-related auditory neuropathy. These devices bypass the impaired synaptic transmission by directly stimulating the auditory nerve, and many individuals achieve substantial benefit from implantation.
Early implantation, ideally before age two years, maximises the potential for age-appropriate speech and language development. Following implantation, intensive auditory-verbal therapy and speech-language support services help individuals develop listening and communication skills. Educational support through local authority services ensures appropriate accommodations in school settings. For individuals who are not candidates for cochlear implantation or who choose not to pursue this intervention, British Sign Language and visual communication strategies provide alternative pathways for language development. Ongoing follow-up through NHS audiology and ear, nose and throat services monitors device function and hearing status over time.
UK care pathway
Families typically enter the care pathway through newborn hearing screening programmes or subsequent audiology assessments identifying hearing concerns. Auditory neuropathy prompts referral to specialist paediatric audiology centres for comprehensive evaluation, including genetic testing. The NHS Genomic Medicine Service facilitates OTOF testing through the hearing loss gene panel (R67), accessible via clinical genetics departments or specialist audiology services. Genetic counsellors support families in understanding test results, recurrence risks and implications for extended family members. Following genetic confirmation, multidisciplinary teams coordinate care through paediatric audiology, cochlear implant programmes, speech-language therapy services and educational psychology support. Local clinical genetics services provide ongoing genetic counselling and coordinate testing for at-risk relatives when requested.
Frequently asked questions
Will hearing aids help my child with OTOF-related auditory neuropathy?
Traditional hearing aids typically provide limited benefit because the problem lies in transmitting sound signals to the brain rather than detecting sound. Cochlear implants, which bypass the impaired synapses and directly stimulate the auditory nerve, generally represent a more effective option for individuals with OTOF variants.
If both my partner and I are carriers, will all our children have hearing loss?
No. When both parents carry one OTOF variant, each pregnancy has a 25% chance of producing an affected child, a 50% chance of a carrier child with normal hearing, and a 25% chance of a child with two typical gene copies. Three-quarters of children will have normal hearing.
Can my child's hearing improve on its own over time?
Whilst hearing can fluctuate in some individuals with OTOF variants, spontaneous significant improvement is uncommon. The underlying genetic cause remains constant, so without intervention such as cochlear implantation, functional hearing typically remains impaired. Early assessment and intervention offer the best outcomes for speech and language development.
Should other family members be tested for OTOF variants?
Testing may be helpful for siblings who are planning families, as knowing carrier status can inform reproductive decisions. Parents of an affected child are both carriers by definition. Genetic counsellors through NHS clinical genetics services can discuss testing options and their implications for interested family members.
Why does my child's hearing test show the ear is working but they still can't hear properly?
The inner ear structures that detect sound vibrations function normally in OTOF-related auditory neuropathy. The problem occurs at the next step, where the electrical signals should be transmitted to the brain. This disconnect explains why some hearing tests show normal responses whilst speech understanding remains severely impaired.